Author [ Title] Type Year
Filters: Author is Bader, Peter [Clear All Filters]
CAR-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-ALL and enhance survival.Int J Cancer.(2016).
Clearance of hematological malignancies by allogeneic cytokine-induced killer cell or donor lymphocyte infusions.Biol Blood Marrow Transplant.(2019).
Cytomegalovirus-specific cytokine-induced killer cells: concurrent targeting of leukemia and cytomegalovirus.Cytotherapy.(2015).
Genetically engineered CAR NK cells display selective cytotoxicity against FLT3-positive B-ALL and inhibit in vivo leukemia growth.Int J Cancer.(2019).
Improving Stratification for Children With Late Bone Marrow B-Cell Acute Lymphoblastic Leukemia Relapses With Refined Response Classification and Integration of Genetics.J Clin OncolJCO1901694.(2019).
Mobilized peripheral blood stem cell apheresis via Hickman catheter in pediatric patients.Transfusion.(2019).
Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study.Bone Marrow Transplant.(2020).
Myeloablative unrelated cord blood transplantation in adolescents and young adults with acute leukemia.Biol Blood Marrow Transplant.(2019).
Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial.Lancet Oncol.(2019).